-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, ST Renfu (600079.SH) issued an announcement. Recently, the company's holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd. (“Yichang Renfu”, the company holds 80% of its shares) received a marketing license approval letter approved by the British Medicines and Health Products Regulatory Authority (MHRA) to approve and issue a marketing license approval letter for dextrose sodium injection.

Zhitongcaijing·10/13/2026 08:09:16
Listen to the news
Zhitong Finance App News, ST Renfu (600079.SH) issued an announcement. Recently, the company's holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd. (“Yichang Renfu”, the company holds 80% of its shares) received a marketing license approval letter approved by the British Medicines and Health Products Regulatory Authority (MHRA) to approve and issue a marketing license approval letter for dextrose sodium injection.